{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:23:26Z","timestamp":1793798606163,"version":"4.6.1"},"reference-count":173,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["ZYXYL2024\\u2013001"],"award-info":[{"award-number":["ZYXYL2024\\u2013001"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["ZYYZDXK-2023083"],"award-info":[{"award-number":["ZYYZDXK-2023083"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007166","name":"Jiangsu Province Department of Education","doi-asserted-by":"publisher","award":["24KJA360007"],"award-info":[{"award-number":["24KJA360007"]}],"id":[{"id":"10.13039\/501100007166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbiological Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.micres.2025.128228","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T12:10:55Z","timestamp":1747829455000},"page":"128228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Phage therapy: A novel approach to combat drug-resistant pathogens"],"prefix":"10.1016","volume":"298","author":[{"given":"Mengru","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-189X","authenticated-orcid":false,"given":"Ping","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micres.2025.128228_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121085","article-title":"Characterization of newly isolated bacteriophage to control multi-drug resistant Pseudomonas aeruginosa colonizing incision wounds in a rat model: in vitro and in vivo approach","volume":"310","author":"Abo Kamer","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/v13020334","article-title":"Improving the inhibitory effect of phages against pseudomonas aeruginosa isolated from a burn patient using a combination of phages and antibiotics","volume":"13","author":"Aghaee","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micres.2025.128228_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121639","article-title":"Characterization and genomic analysis of novel bacteriophage NK20 to revert colistin resistance and combat pandrug-resistant Klebsiella pneumoniae in a rat respiratory infection model","volume":"322","author":"Al-Madboly","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.micres.2025.128228_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198250","article-title":"A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa","volume":"292","author":"Alvi","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.micres.2025.128228_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","article-title":"Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model","volume":"21","author":"Anand","year":"2020","journal-title":"J. Glob. Antimicrob. Resist"},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/v13102005","article-title":"In vitro characterization and in vivo efficacy assessment in galleria mellonella larvae of newly isolated bacteriophages against escherichia coli K1","volume":"13","author":"Antoine","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12866-022-02603-0","article-title":"Antibacterial efficacy of lytic phages against multidrug-resistant Pseudomonas aeruginosa infections in bacteraemia mice models","volume":"22","author":"Arumugam","year":"2022","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41587-025-02570-7","article-title":"Sustained in situ protein production and release in the mammalian gut by an engineered bacteriophage","author":"Baker","year":"2025","journal-title":"Nat. Biotechnol."},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrmicro3076","article-title":"A problem of persistence: still more questions than answers?","volume":"11","author":"Balaban","year":"2013","journal-title":"Nat. Rev. Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib10","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.addr.2018.12.013","article-title":"Phage-based vaccines","volume":"145","author":"Bao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"23","key":"10.1016\/j.micres.2025.128228_bib11","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104592118","article-title":"Coevolutionary phage training leads to greater bacterial suppression and delays the evolution of phage resistance","volume":"118","author":"Borin","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micres.2025.128228_bib13","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fmicb.2020.01161","article-title":"Good manufacturing practice (GMP) compliance for phage therapy medicinal products","volume":"11","author":"Bretaudeau","year":"2020","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/v15040887","article-title":"Effective treatment of staphylococcus aureus intramammary infection in a murine model using the bacteriophage cocktail staphLyse\u2122","volume":"15","author":"Brouillette","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1128\/IAI.73.1.325-333.2005","article-title":"A peptide mimotope of type 8 pneumococcal capsular polysaccharide induces a protective immune response in mice","volume":"73","author":"Buchwald","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.micres.2025.128228_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.mib.2021.10.013","article-title":"The multifaceted lifestyle of enterococci: genetic diversity, ecology and risks for public health","volume":"65","author":"Cattoir","year":"2022","journal-title":"Curr. Opin. Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib17","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1111\/jam.15439","article-title":"Characterization, genome analysis and in vitro activity of a novel phage vB_EcoA_RDN8.1 active against multi-drug resistant and extensively drug-resistant biofilm-forming uropathogenic Escherichia coli isolates, India","volume":"132","author":"Chaudhary","year":"2022","journal-title":"J. Appl. Microbiol"},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijmmb.2021.04.011","article-title":"Characterization and in vitro activity of a lytic phage RDN37 isolated from community sewage water active against MDR Uropathogenic E. coli","volume":"39","author":"Chaudhary","year":"2021","journal-title":"Indian J. Med Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12941-020-00389-5","article-title":"Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review","volume":"19","author":"Chegini","year":"2020","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"key":"10.1016\/j.micres.2025.128228_bib20","article-title":"Enteric phageome alterations in patients with type 2 diabetes","volume":"10","author":"Chen","year":"2020","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41522-024-00552-2","article-title":"Combination of bacteriophages and vancomycin in a co-delivery hydrogel for localized treatment of fracture-related infections","volume":"10","author":"Chen","year":"2024","journal-title":"NPJ Biofilms Micro"},{"key":"10.1016\/j.micres.2025.128228_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198750","article-title":"Isolation, characterization, and genome analysis of bacteriophage P929 that could specifically lyase the KL19 capsular type of Klebsiella pneumoniae","volume":"314","author":"Chen","year":"2022","journal-title":"Virus Res"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib23","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/21505594.2021.1878688","article-title":"Pathogenicity and virulence of Staphylococcus aureus","volume":"12","author":"Cheung","year":"2021","journal-title":"Virulence"},{"issue":"9","key":"10.1016\/j.micres.2025.128228_bib24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cmi.2021.05.034","article-title":"The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children: a systematic review and meta-analysis","volume":"27","author":"Claassen-Weitz","year":"2021","journal-title":"Clin. Microbiol Infect."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cell.2019.12.034","article-title":"Bacteriophage prevents alcoholic liver disease","volume":"180","author":"\u00c7olako\u011flu","year":"2020","journal-title":"Cell"},{"issue":"10325","key":"10.1016\/j.micres.2025.128228_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Collaborators","year":"2022","journal-title":"Lancet"},{"issue":"10459","key":"10.1016\/j.micres.2025.128228_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050","volume":"404","author":"Collaborators","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.micres.2025.128228_bib28","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S1473-3099(24)00176-2","article-title":"Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"24","author":"Collaborators","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02212-17","article-title":"Chemotherapy with phage lysins reduces pneumococcal colonization of the respiratory tract","volume":"62","author":"Corsini","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies","volume":"83","author":"D\u0105browska","year":"2019","journal-title":"Microbiol Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00181-19","article-title":"Antimicrobial Resistance in ESKAPE pathogens","volume":"33","author":"De Oliveira","year":"2020","journal-title":"Clin. Microbiol Rev."},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cmi.2019.08.006","article-title":"Pathogenesis and management of fracture-related infection","volume":"26","author":"Depypere","year":"2020","journal-title":"Clin. Microbiol Infect."},{"key":"10.1016\/j.micres.2025.128228_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103998","article-title":"Klebsiella species: taxonomy, hypervirulence and multidrug resistance","volume":"79","author":"Dong","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib34","doi-asserted-by":"crossref","first-page":"4337","DOI":"10.1038\/s41467-023-39612-0","article-title":"Enhancing bacteriophage therapeutics through in situ production and release of heterologous antimicrobial effectors","volume":"14","author":"Du","year":"2023","journal-title":"Nat. Commun."},{"issue":"7783","key":"10.1016\/j.micres.2025.128228_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-019-1742-x","article-title":"Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease","volume":"575","author":"Duan","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics13020195","article-title":"Potential of an isolated bacteriophage to inactivate klebsiella pneumoniae: preliminary studies to control urinary tract infections","volume":"13","author":"Duarte","year":"2024","journal-title":"Antibiotics"},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10080946","article-title":"Successful intratracheal treatment of phage and antibiotic combination therapy of a multi-drug resistant pseudomonas aeruginosa murine model","volume":"10","author":"Duplessis","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib38","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01996-21","article-title":"Case commentary: novel therapy for multidrug-resistant acinetobacter baumannii infection","volume":"66","author":"Eales","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12866-021-02251-w","article-title":"Isolation and characterization of lytic phage TUN1 specific for Klebsiella pneumoniae K64 clinical isolates from Tunisia","volume":"21","author":"Eckstein","year":"2021","journal-title":"BMC Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41467-021-27656-z","article-title":"Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae","volume":"13","author":"Eskenazi","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.micres.2025.128228_bib41","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7326\/L19-0369","article-title":"Polyclonal staphylococcus aureus bacteremia","volume":"171","author":"Fabijan","year":"2019","journal-title":"Ann. Intern. Med."},{"issue":"12","key":"10.1016\/j.micres.2025.128228_bib42","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1469-0691.2004.01035.x","article-title":"Antimicrobial resistance of Acinetobacter spp. in Europe","volume":"10","author":"Falagas","year":"2004","journal-title":"Clin. Microbiol Infect."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/v16030443","article-title":"The medicinal phage-regulatory roadmap for phage therapy under EU pharmaceutical legislation","volume":"16","author":"Faltus","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","article-title":"Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden","volume":"28","author":"Foxman","year":"2014","journal-title":"Infect. Dis. Clin. North Am."},{"issue":"8023","key":"10.1016\/j.micres.2025.128228_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-024-07667-8","article-title":"An enterococcal phage-derived enzyme suppresses graft-versus-host disease","volume":"632","author":"Fujimoto","year":"2024","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047742","article-title":"Pseudomonas aeruginosa keratitis in mice: effects of topical bacteriophage KPP12 administration","volume":"7","author":"Fukuda","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib47","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02358-22","article-title":"Bacteriophage Effectively Rescues Pneumonia Caused by Prevalent Multidrug-Resistant Klebsiella pneumoniae in the Early Stage","volume":"10","author":"Gan","year":"2022","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.micres.2025.128228_bib48","article-title":"Resistance against two lytic phage variants attenuates virulence and antibiotic resistance in Pseudomonas aeruginosa","volume":"13","author":"Garc\u00eda-Cruz","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1473-3099(18)30708-4","article-title":"Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in Switzerland","volume":"19","author":"Gasser","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micres.2025.128228_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s11262-024-02106-2","article-title":"Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model","author":"Geng","year":"2024","journal-title":"Virus Genes"},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib51","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tim.2017.11.008","article-title":"Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship","volume":"26","author":"Geoghegan","year":"2018","journal-title":"Trends Microbiol"},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24497","article-title":"Isolation of a lytic bacteriophage against extensively drug-resistant Acinetobacter baumannii infections and its dramatic effect in rat model of burn infection","volume":"36","author":"Ghaznavi-Rad","year":"2022","journal-title":"J. Clin. Lab Anal."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5694\/mja2.50274","article-title":"Adjunctive bacteriophage therapy for prosthetic valve endocarditis due to Staphylococcus aureus","volume":"211","author":"Gilbey","year":"2019","journal-title":"Med J. Aust."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00705-022-05680-8","article-title":"Characterization and genome analysis of Escherichia phage fBC-Eco01, isolated from wastewater in Tunisia","volume":"168","author":"Grami","year":"2023","journal-title":"Arch. Virol."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib55","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.pop.2013.06.004","article-title":"Upper respiratory infections","volume":"40","author":"Grief","year":"2013","journal-title":"Prim. Care"},{"key":"10.1016\/j.micres.2025.128228_bib56","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fcimb.2017.00286","article-title":"Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus","volume":"7","author":"Guerra","year":"2017","journal-title":"Front Cell Infect. Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3389\/fmicb.2014.00184","article-title":"Clostridium difficile phages: still difficult?","volume":"5","author":"Hargreaves","year":"2014","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib58","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0040-1709992","article-title":"Staphylococcus aureus Pneumonia in the Community","volume":"41","author":"He","year":"2020","journal-title":"Semin Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib59","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00034-21","article-title":"Bacteriophage treatment rescues mice infected with multidrug-resistant klebsiella pneumoniae ST258","volume":"12","author":"Hesse","year":"2021","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib60","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1038\/s41598-020-62691-8","article-title":"Identification of a newly isolated lytic bacteriophage against K24 capsular type, carbapenem resistant Klebsiella pneumoniae isolates","volume":"10","author":"Horv\u00e1th","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10071324","article-title":"Phage products for fighting antimicrobial resistance","volume":"10","author":"Huang","year":"2022","journal-title":"Microorganisms"},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib62","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1007\/s11033-021-06690-6","article-title":"Multidrug-resistant acinetobacter baumannii as an emerging concern in hospitals","volume":"48","author":"Ibrahim","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0031-2018","article-title":"Regulation of staphylococcus aureus virulence","volume":"7","author":"Jenul","year":"2019","journal-title":"Microbiol Spectr."},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib64","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib65","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/14787210.2019.1646126","article-title":"Factors determining phage stability\/activity: challenges in practical phage application","volume":"17","author":"Jo\u0144czyk-Matysiak","year":"2019","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib66","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202102539","article-title":"Bacteriophage-loaded poly(lactic-co-glycolic acid) microparticles mitigate staphylococcus aureus infection and cocultures of staphylococcus aureus and pseudomonas aeruginosa","volume":"11","author":"Kalelkar","year":"2022","journal-title":"Adv. Health Mater."},{"key":"10.1016\/j.micres.2025.128228_bib67","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jss.2021.10.010","article-title":"Identifying causative microorganisms in left ventricular assist device infections as a guide for developing bacteriophage therapy","volume":"271","author":"Kamat","year":"2022","journal-title":"J. Surg. Res"},{"issue":"12","key":"10.1016\/j.micres.2025.128228_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4254\/wjh.v4.i12.335","article-title":"Management of alcoholic hepatitis: current concepts","volume":"4","author":"Karsan","year":"2012","journal-title":"World J. Hepatol."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib69","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00408-024-00700-7","article-title":"Phage therapy for respiratory infections: opportunities and challenges","volume":"202","author":"Khosravi","year":"2024","journal-title":"Lung"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib70","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12866-020-01891-8","article-title":"Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus","volume":"20","author":"Kifelew","year":"2020","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00424-9","article-title":"Safety, pharmacokinetics, and pharmacodynamics of LBP-EC01, a CRISPR-Cas3-enhanced bacteriophage cocktail, in uncomplicated urinary tract infections due to Escherichia coli (ELIMINATE): the randomised, open-label, first part of a two-part phase 2 trial","author":"Kim","year":"2024","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib72","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1038\/s41467-023-39370-z","article-title":"Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa","volume":"14","author":"K\u00f6hler","year":"2023","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/v16071000","article-title":"Combinations of bacteriophage are efficacious against multidrug-resistant pseudomonas aeruginosa and enhance sensitivity to carbapenem antibiotics","volume":"16","author":"Kovacs","year":"2024","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115369","article-title":"Characterization and host range prediction of Staphylococcus aureus phages through receptor-binding protein analysis","volume":"44","author":"Krusche","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.micres.2025.128228_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.106467","article-title":"Bacteriophage therapy against ESKAPE bacterial pathogens: current status, strategies, challenges, and future scope","volume":"186","author":"Kulshrestha","year":"2024","journal-title":"Micro Pathog."},{"key":"10.1016\/j.micres.2025.128228_bib76","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mib.2020.02.005","article-title":"Staphylococcus aureus bloodstream infections: pathogenesis and regulatory mechanisms","volume":"53","author":"Kwiecinski","year":"2020","journal-title":"Curr. Opin. Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib77","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1089\/sur.2020.346","article-title":"Burn wound colonization, infection, and sepsis","volume":"22","author":"Ladhani","year":"2021","journal-title":"Surg. Infect. (Larchmt. )"},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/v14051079","article-title":"In vitro and in vivo assessments of two newly isolated bacteriophages against an ST13 urinary tract infection klebsiella pneumoniae","volume":"14","author":"Lafor\u00eat","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy064","article-title":"Phage therapy for a multidrug-resistant acinetobacter baumannii craniectomy site infection","volume":"5","author":"LaVergne","year":"2018","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib80","doi-asserted-by":"crossref","DOI":"10.3390\/v11010088","article-title":"Design and preclinical development of a phage product for the treatment of antibiotic-resistant staphylococcus aureus infections","volume":"11","author":"Lehman","year":"2019","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib81","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.jaci.2020.02.038","article-title":"The role of neutrophils in host defense and disease","volume":"145","author":"Lehman","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib82","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1146\/annurev-virology-092917-043544","article-title":"Phage-based applications in synthetic biology","volume":"5","author":"Lemire","year":"2018","journal-title":"Annu Rev. Virol."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib83","first-page":"95","article-title":"Application of phagotherapy in the treatment of burn patients review","volume":"2","author":"Leontyev","year":"2021","journal-title":"Sovrem. Tekhnologii Med. 1"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib84","doi-asserted-by":"crossref","first-page":"9251","DOI":"10.1038\/s41598-024-59903-w","article-title":"Isolation and characterisation of a novel Silviavirus bacteriophage promising antimicrobial agent against methicillin-resistant Staphylococcus aureus infections","volume":"14","author":"Lerdsittikul","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micres.2025.128228_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120200","article-title":"Phage cocktail powder for Pseudomonas aeruginosa respiratory infections","volume":"596","author":"Li","year":"2021","journal-title":"Int J. Pharm."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib86","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00467-24","article-title":"In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model","volume":"98","author":"Li","year":"2024","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.micres.2025.128228_bib87","doi-asserted-by":"crossref","first-page":"1601.e1","DOI":"10.1016\/j.cmi.2023.08.022","article-title":"Development of phage resistance in multidrug-resistant Klebsiella pneumoniae is associated with reduced virulence: a case report of a personalised phage therapy","volume":"29","author":"Li","year":"2023","journal-title":"Clin. Microbiol Infect."},{"issue":"1-2","key":"10.1016\/j.micres.2025.128228_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.09.024","article-title":"Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa","volume":"551","author":"Lin","year":"2018","journal-title":"Int J. Pharm."},{"issue":"28","key":"10.1016\/j.micres.2025.128228_bib89","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1021\/acs.nanolett.4c02318","article-title":"Inhalable POlymeric Microparticles for Phage and Photothermal Synergistic Therapy of Methicillin-resistant Staphylococcus Aureus Pneumonia","volume":"24","author":"Liu","year":"2024","journal-title":"Nano Lett."},{"issue":"52","key":"10.1016\/j.micres.2025.128228_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202412154","article-title":"LysSYL-Loaded pH-Switchable self-assembling peptide hydrogels promote methicillin-resistant staphylococcus aureus elimination and wound healing","volume":"36","author":"Liu","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.micres.2025.128228_bib91","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2147\/IDR.S180283","article-title":"Pseudomonas aeruginosa bacteremia among liver transplant recipients","volume":"11","author":"Liu","year":"2018","journal-title":"Infect. Drug Resist"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4149\/av_2021_203","article-title":"Anti-biofilm activity of bacteriophages and lysins in chronic rhinosinusitis","volume":"65","author":"\u0141usiak-Szelachowska","year":"2021","journal-title":"Acta Virol."},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib93","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/vim.2013.0128","article-title":"Phage neutralization by sera of patients receiving phage therapy","volume":"27","author":"\u0141usiak-Szelachowska","year":"2014","journal-title":"Viral Immunol."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib94","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41467-023-44157-3","article-title":"Phage Paride can kill dormant, antibiotic-tolerant cells of Pseudomonas aeruginosa by direct lytic replication","volume":"15","author":"Maffei","year":"2024","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.14740\/cr755w","article-title":"A community level sample survey to determine currentunderstanding about medical recycling of cardiovascular implantableelectronic devices","volume":"9","author":"Mahesh","year":"2018","journal-title":"Cardiol. Res"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib96","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12223-019-00750-y","article-title":"Managing urinary tract infections through phage therapy: a novel approach","volume":"65","author":"Malik","year":"2020","journal-title":"Folia Microbiol (Praha)"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib97","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1038\/s41467-023-39863-x","article-title":"Engineered reporter phages for detection of Escherichia coli, Enterococcus, and Klebsiella in urine","volume":"14","author":"Meile","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/v14030490","article-title":"Immune response of an oral enterococcus faecalis phage cocktail in a mouse model of ethanol-induced liver disease","volume":"14","author":"Mendes","year":"2022","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib99","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmi.2023.01.011","article-title":"Bacteriophage therapy for human musculoskeletal and skin\/soft tissue infections","volume":"29","author":"Metsemakers","year":"2023","journal-title":"Clin. Microbiol Infect."},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib100","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib101","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms","volume":"44","author":"Miller","year":"2020","journal-title":"FEMS Microbiol Rev."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib102","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/s41467-023-41391-7","article-title":"NLRP3 selectively drives IL-1\u03b2 secretion by Pseudomonas aeruginosa infected neutrophils and regulates corneal disease severity","volume":"14","author":"Minns","year":"2023","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.micres.2025.128228_bib103","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00650-24","article-title":"Bacteriophage therapy reduces Staphylococcus aureus in a porcine and human ex vivo burn wound infection model","volume":"68","author":"Molendijk","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micres.2025.128228_bib104","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","article-title":"Emerging strategies to combat eskape pathogens in the era of antimicrobial resistance: a review","volume":"10","author":"Mulani","year":"2019","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MAT.0000000000000684","article-title":"Left ventricular assist device infections: a systematic review","volume":"64","author":"O'Horo","year":"2018","journal-title":"Asaio J."},{"issue":"10442","key":"10.1016\/j.micres.2025.128228_bib106","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0140-6736(24)00876-6","article-title":"The scope of the antimicrobial resistance challenge","volume":"403","author":"Okeke","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib107","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01736-21","article-title":"Bacteriophage therapy for the prevention and treatment of fracture-related infection caused by staphylococcus aureus: a preclinical study","volume":"9","author":"Onsea","year":"2021","journal-title":"Microbiol Spectr."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib108","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","article-title":"Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies","volume":"37","author":"Pang","year":"2019","journal-title":"Biotechnol. Adv."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib109","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1021\/acs.chemrev.4c00681","article-title":"Engineering phages to fight multidrug-resistant bacteria","volume":"125","author":"Peng","year":"2025","journal-title":"Chem. Rev."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41564-019-0634-z","article-title":"Safety of bacteriophage therapy in severe Staphylococcus aureus infection","volume":"5","author":"Petrovic Fabijan","year":"2020","journal-title":"Nat. Microbiol"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib111","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-0041-1740583","article-title":"Methicillin-resistant staphylococcus aureus hospital-acquired pneumonia\/ventilator-associated pneumonia","volume":"43","author":"Pickens","year":"2022","journal-title":"Semin Respir. Crit. Care Med"},{"key":"10.1016\/j.micres.2025.128228_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.907314","article-title":"Bacteriophage therapy for staphylococcus aureus infections: a review of animal models, treatments, and clinical trials","volume":"12","author":"Plumet","year":"2022","journal-title":"Front Cell Infect. Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib113","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors","volume":"11","author":"Podschun","year":"1998","journal-title":"Clin. Microbiol Rev."},{"issue":"9","key":"10.1016\/j.micres.2025.128228_bib114","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1164\/rccm.201812-2372OC","article-title":"Bacteriophages improve outcomes in experimental staphylococcus aureus ventilator-associated pneumonia","volume":"200","author":"Prazak","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib115","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/infdis\/jiab112","article-title":"Benefits of aerosolized phages for the treatment of pneumonia due to methicillin-resistant staphylococcus aureus: an experimental study in rats","volume":"225","author":"Prazak","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib116","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00472-23","article-title":"Engineered superinfective pf phage prevents dissemination of pseudomonas aeruginosa in a mouse burn model","volume":"14","author":"Prokopczuk","year":"2023","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.micres.2025.128228_bib117","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11101310","article-title":"Local treatment of driveline infection with bacteriophages","volume":"11","author":"P\u00fcschel","year":"2022","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib118","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41392-022-01056-1","article-title":"Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics","volume":"7","author":"Qin","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib119","doi-asserted-by":"crossref","first-page":"281","DOI":"10.34172\/bi.2021.10","article-title":"Evaluation of in-situ gel-forming eye drop containing bacteriophage against Pseudomonas aeruginosa keratoconjunctivitis in vivo","volume":"11","author":"Rahimzadeh","year":"2021","journal-title":"Bioimpacts"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib120","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00824-21","article-title":"Critically Ill patient with multidrug-resistant acinetobacter baumannii respiratory infection successfully treated with intravenous and nebulized bacteriophage therapy","volume":"66","author":"Rao","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib121","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00024-19","article-title":"Isolation of phage lysins that effectively kill pseudomonas aeruginosa in mouse models of lung and skin infection","volume":"63","author":"Raz","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib122","first-page":"190","article-title":"Infective endocarditis - A review of current therapy and future challenges","volume":"62","author":"Rezar","year":"2021","journal-title":"Hell. J. Cardiol."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib123","doi-asserted-by":"crossref","DOI":"10.1186\/s43141-022-00409-1","article-title":"Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model","volume":"20","author":"Rezk","year":"2022","journal-title":"J. Genet Eng. Biotechnol."},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib124","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.micres.2025.128228_bib125","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijid.2022.04.049","article-title":"Case Report: successful use of phage therapy in refractory MRSA chronic rhinosinusitis","volume":"121","author":"Rodriguez","year":"2022","journal-title":"Int J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics11050602","article-title":"Bacteriophage-enriched galenic for intrapericardial ventricular assist device infection","volume":"11","author":"Rojas","year":"2022","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib127","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1067\/mda.2003.8","article-title":"The etiology of urinary tract infection: traditional and emerging pathogens","volume":"49","author":"Ronald","year":"2003","journal-title":"Dis. Mon."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib128","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.023080","article-title":"Bacteriophages combined with subtherapeutic doses of flucloxacillin act synergistically against staphylococcus aureus experimental infective endocarditis","volume":"11","author":"Save","year":"2022","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40560-024-00759-7","article-title":"Current status of bacteriophage therapy for severe bacterial infections","volume":"12","author":"Sawa","year":"2024","journal-title":"J. Intensive Care"},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib130","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cpt.2214","article-title":"Reapproaching old treatments: considerations for pk\/pd studies on phage therapy for bacterial respiratory infections","volume":"109","author":"Schmalstig","year":"2021","journal-title":"Clin. Pharm. Ther."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.micres.2025.128228_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1025633","article-title":"The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic","volume":"10","author":"Shariati","year":"2022","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib133","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41598-020-57559-w","article-title":"Wound healing properties and antimicrobial activity of platelet-derived biomaterials","volume":"10","author":"Shariati","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib134","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/jam.13078","article-title":"Escherichia coli biofilm: development and therapeutic strategies","volume":"121","author":"Sharma","year":"2016","journal-title":"J. Appl. Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.613356","article-title":"Safety and efficacy of a Phage, kpssk3, in an in vivo model of carbapenem-resistant hypermucoviscous klebsiella pneumoniae bacteremia","volume":"12","author":"Shi","year":"2021","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib136","doi-asserted-by":"crossref","DOI":"10.3390\/v13010007","article-title":"Staphylococcal phage in combination with staphylococcus epidermidis as a potential treatment for staphylococcus aureus-associated atopic dermatitis and suppressor of phage-resistant mutants","volume":"13","author":"Shimamori","year":"2020","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib137","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s00284-021-02395-y","article-title":"Isolation and Characterization of a Novel Phage SaGU1 that Infects Staphylococcus aureus Clinical Isolates from Patients with Atopic Dermatitis","volume":"78","author":"Shimamori","year":"2021","journal-title":"Curr. Microbiol"},{"issue":"4","key":"10.1016\/j.micres.2025.128228_bib138","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1574-6976.2011.00269.x","article-title":"Pseudomonas genomes: diverse and adaptable","volume":"35","author":"Silby","year":"2011","journal-title":"FEMS Microbiol Rev."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib139","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.micres.2025.128228_bib140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jgar.2024.07.019","article-title":"Evaluation of bacteriophage cocktail on urinary tract infection caused by colistin-resistant Klebsiella pneumoniae in mice model","volume":"39","author":"Singh","year":"2024","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"10.1016\/j.micres.2025.128228_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.778676","article-title":"Evaluation of bacteriophage cocktail on septicemia caused by colistin-resistant klebsiella pneumoniae in mice model","volume":"13","author":"Singh","year":"2022","journal-title":"Front Pharm."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib142","doi-asserted-by":"crossref","DOI":"10.3390\/v13071348","article-title":"Characterization of anti-bacterial effect of the two new phages against uropathogenic escherichia coli","volume":"13","author":"Slobodn\u00edkov\u00e1","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032459","article-title":"Phage engineering for targeted multidrug-resistant escherichia coli","volume":"24","author":"Song","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib144","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1086\/524891","article-title":"The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America","volume":"46","author":"Spellberg","year":"2008","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2022.11.017","article-title":"Phage therapy: From biological mechanisms to future directions","volume":"186","author":"Strathdee","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.micres.2025.128228_bib146","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jgar.2020.12.025","article-title":"Exploring the future of infectious disease treatment in a post-antibiotic era: A comparative review of alternative therapeutics","volume":"24","author":"Streicher","year":"2021","journal-title":"J. Glob. Antimicrob. Resist"},{"key":"10.1016\/j.micres.2025.128228_bib147","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.2147\/DDDT.S251171","article-title":"Bacteriophages, a new therapeutic solution for inhibiting multidrug-resistant bacteria causing wound infection: lesson from animal models and clinical trials","volume":"14","author":"Taati Moghadam","year":"2020","journal-title":"Drug Des. Devel Ther."},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib148","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.micinf.2014.02.011","article-title":"Experimental phage therapy against lethal lung-derived septicemia caused by Staphylococcus aureus in mice","volume":"16","author":"Takemura-Uchiyama","year":"2014","journal-title":"Microbes Infect."},{"issue":"3","key":"10.1016\/j.micres.2025.128228_bib149","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.BAI-0014-2019","article-title":"Reaching the end of the line: urinary tract infections","volume":"7","author":"Tamadonfar","year":"2019","journal-title":"Microbiol Spectr."},{"issue":"11","key":"10.1016\/j.micres.2025.128228_bib150","doi-asserted-by":"crossref","DOI":"10.3390\/v11111080","article-title":"Characterization of Klebsiella pneumoniae ST11 isolates and their interactions with lytic phages","volume":"11","author":"Tan","year":"2019","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003495","article-title":"Mutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccines","volume":"9","author":"Tao","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.micres.2025.128228_bib152","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","article-title":"UroPathogenic escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies","volume":"8","author":"Terlizzi","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micres.2025.128228_bib153","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/354250","article-title":"Atopic dermatitis: natural history, diagnosis, and treatment","volume":"2014","author":"Thomsen","year":"2014","journal-title":"ISRN Allergy"},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/v13020318","article-title":"Phage-bacteria interactions in potential applications of bacteriophage vB_EfaS-271 against enterococcus faecalis","volume":"13","author":"Topka-Bielecka","year":"2021","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib155","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1253\/circj.CJ-13-0296","article-title":"Present status and future perspectives of heart transplantation","volume":"77","author":"Toyoda","year":"2013","journal-title":"Circ. J."},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib156","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.1016\/S1473-3099(21)00612-5","article-title":"Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review","volume":"22","author":"Uyttebroek","year":"2022","journal-title":"Lancet Infect. Dis."},{"issue":"2","key":"10.1016\/j.micres.2025.128228_bib157","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10020145","article-title":"Pseudomonas aeruginosa resistance to bacteriophages and its prevention by strategic therapeutic cocktail formulation","volume":"10","author":"Vaitekenas","year":"2021","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib158","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s13104-021-05796-1","article-title":"Searching for synergy: combining systemic daptomycin treatment with localised phage therapy for the treatment of experimental pneumonia due to MRSA","volume":"14","author":"Valente","year":"2021","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib159","doi-asserted-by":"crossref","first-page":"5725","DOI":"10.1038\/s41467-022-33294-w","article-title":"Bacteriophage-antibiotic combination therapy against extensively drug-resistant Pseudomonas aeruginosa infection to allow liver transplantation in a toddler","volume":"13","author":"Van Nieuwenhuyse","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2025.128228_bib160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.coviro.2021.11.005","article-title":"European regulatory aspects of phage therapy: magistral phage preparations","volume":"52","author":"Verbeken","year":"2022","journal-title":"Curr. Opin. Virol."},{"issue":"8","key":"10.1016\/j.micres.2025.128228_bib161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160242","article-title":"The effectiveness of bacteriophages against methicillin-resistant staphylococcus aureus st398 nasal colonization in pigs","volume":"11","author":"Verstappen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.micres.2025.128228_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.198951","article-title":"Comparison of the therapeutic potential of bacteriophage KpV74 and phage-derived depolymerase (\u03b2-glucosidase) against Klebsiella pneumoniae capsular type K2","volume":"322","author":"Volozhantsev","year":"2022","journal-title":"Virus Res."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib163","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jama.2018.7596","article-title":"Management considerations in infective endocarditis: a review","volume":"320","author":"Wang","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.micres.2025.128228_bib164","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/fmb.16.11","article-title":"Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia","volume":"11","author":"Wang","year":"2016","journal-title":"Future Microbiol"},{"issue":"33","key":"10.1016\/j.micres.2025.128228_bib165","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309972","article-title":"Data-driven engineering of phages with tunable capsule tropism for klebsiella pneumoniae","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"issue":"7","key":"10.1016\/j.micres.2025.128228_bib166","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.micres.2025.128228_bib167","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1473-3099(05)70295-4","article-title":"The role of nasal carriage in Staphylococcus aureus infections","volume":"5","author":"Wertheim","year":"2005","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"10.1016\/j.micres.2025.128228_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177266","article-title":"Antibiotic resistance rates and physician antibiotic prescription patterns of uncomplicated urinary tract infections in southern Chinese primary care","volume":"12","author":"Wong","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib169","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/22221751.2021.1902754","article-title":"Pre-optimized phage therapy on secondary Acinetobacter baumannii infection in four critical COVID-19 patients","volume":"10","author":"Wu","year":"2021","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12941-017-0191-3","article-title":"Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae","volume":"16","author":"Xu","year":"2017","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"issue":"1","key":"10.1016\/j.micres.2025.128228_bib171","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/s41598-020-63048-x","article-title":"Isolation, characterization and genomic analysis of a novel bacteriophage vb_ecos-golestan infecting multidrug-resistant escherichia coli isolated from urinary tract infection","volume":"10","author":"Yazdi","year":"2020","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.micres.2025.128228_bib172","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12223-020-00775-8","article-title":"Biological characteristics and genome analysis of a novel phage vB_KpnP_IME279 infecting Klebsiella pneumoniae","volume":"65","author":"Zhang","year":"2020","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.micres.2025.128228_bib173","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fmed.2017.00094","article-title":"Phage therapy in a 16-year-old boy with netherton syndrome","volume":"4","author":"Zhvania","year":"2017","journal-title":"Front. Med."}],"container-title":["Microbiological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501325001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501325001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:45:02Z","timestamp":1762332302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944501325001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":173,"alternative-id":["S0944501325001843"],"URL":"https:\/\/doi.org\/10.1016\/j.micres.2025.128228","relation":{},"ISSN":["0944-5013"],"issn-type":[{"value":"0944-5013","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phage therapy: A novel approach to combat drug-resistant pathogens","name":"articletitle","label":"Article Title"},{"value":"Microbiological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micres.2025.128228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128228"}}